ARCHIVES

Also Bristol-Myers Squibb Under Federal Investigation Over Plavix Deal.

This article is from The Cancer Letter archive.

Vol. 32 No. 29 | July 28, 2006

Download PDF Visit The Full Archive

Related Articles

Blincyto Demonstrates Response In Minimal Residual Disease ALL

December 26, 2014

In Brief: VP-16 NDA Approved By FDA Only For Refractory Testicular Cancer; Removed From Group C List

December 2, 1983

Congress Hasn’t Completed Action Yet On Major Health Bills; Reauthorization Fight In 1988-89

July 17, 1987

In Brief: Rosenberg, Taniguchi To Share Hammer 1985 Prize; Dennis Cain Moves To DCT From DEA Grants Review

December 6, 1985

Program Announcements For Tobacco Research

January 21, 1983

Breast Cancer Task Force Hears Update on Research, Abstract Excerpter

September 19, 1980